Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors

American Journal of Pathology

Volumn 148, Issue 2, 1996, Pages 473-483

  Colombo, Mario P ^a   Lombardi, Luciano ^a   Melani, Cecilia ^a   Parenza, Mariella ^a   Baroni, Carlo ^b   Ruco, Luigi ^b   Stoppacciaro, Antonella ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL VACUOLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOLYSIS; ENDOTHELIUM CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; CELL ADHESION MOLECULES; CELL DEATH; CELL HYPOXIA; COLONIC NEOPLASMS; E-SELECTIN; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; NECROSIS; NEOPLASM TRANSPLANTATION; REMISSION INDUCTION; RNA, MESSENGER; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030023747     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Colombo MP, Modesti A, Parmiani G, Forni G Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res 1992, 52:4853-4857
2. Tepper RI, Pattengale PK, Leder P: Murine interleukin-4 displays potent anti-tumor activity in vivo Cell 1989, 57.503-512
3. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffe LM, Karsuyama H, Baker H, Pardoll DW: Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4 Science 1991, 254:719-721
4. + cell-dependent tumor rejection. J Exp Med 1989, 174 1291-1298
5. Blankenstein T, Qin Z, Uberla K, Rosen H, Volk HD, Diamanstein T Tumor suppression after tumor cell-targeted tumor necrosis a gene transfer. J Exp Med 1991, 173:1047-1052
6. Russel SJ, Eccles SA, Flemming CL, Johnson CA, Collins MKL. Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA. Int J Cancer 1991, 47:244-251
7. Sun WH, Kreisle RA, Phillips AW, Ershler WB: In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells, 1992. Cancer Res 52:5412-5415
8. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol 1992, 149.3627-3635
9. Stoppacciaro A, Melani C, Parenza M, Mastracchio A, Bassi C, Baroni C, Parmiani G, Colombo MP. Regression of an established tumor genetically modified to release G-CSF requires granulocyte-T cell cooperation and T cell-produced IFNγ J Exp Med 1993, 178.151-161
10. Colombo MP, Ferrari G, Stoppacciaro A, Parenza M, Rodolfo M, Mavilio F, Parmiani G. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo J Exp Med 1991, 173.889-897.
11. Vecchi A, Garlanda C, Lampugnani MG, Resnati M Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A, Dejana B. Monoclonal antibodies specific for endothehal cells of mouse blood vessels Their application in the identification of adult and embryonic endothelium Eur J Cell Biol 1994, 63:247-254
12. Perussia B, Kobayashi M, Rossi ME, Anegon I, Trinchien G. Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor J Immunol 1987, 138 765-771
13. Old LJ: Tumor necrosis factor (TNF) Science 1985 230 630-632
14. Berent MJ, North RJ, Kirstein DP. The immunological basis of endotoxin-induced tumor regression Requirement for a pre-existing state of concomitant anti-tumor immunity. J Exp Med 1978, 148:1560-1569.
15. MacPherson GG, North RJ: Endotoxin-mediated necrosis and regression of established tumors in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology Cancer Immunol Immunother 1986, 21:209-216
16. Engler R Granulocytes and oxidative injury in myocardial ischemia and reperfusion. Fed Proc 1987, 46. 2395-2396
17. Colombo MP, Lombardi L, Stoppacciaro A, Melani M, Parenza M, Bottazzi B, Parmiani G: Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo J Immunol 1992, 149:113-119
18. Pelletier RP, Ohye RG, Vanbuskirk A, Sedmak DD, Kincade P, Ferguson RM, Orosz CG. Importance of endothelial VCAM-1 tor inflammatory leukocytic infiltration in vivo. J Immunol 1992, 149 2473-2481
19. Westling WF, Gimbrone MA. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation Am J Pathol 1993, 142 117-128
20. Denekamp J: Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev 1990, 9:267-282
21. Burrows FJ, Thorpe PE: Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci USA 1993, 90: 8996-9000